North America Cell Line Development Market to Hit $2.7 Bn by 2024: Sartorius, Samsung Biologics, GE Healthcare, Thermo Fisher Scientific
U.S. cell line development market held largest market share of USD 1.0 billion in 2017 owing to growing reimbursements from public and private insurers, presence of sophisticated healthcare facilities.
View full press release